Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X1TN
|
||||
Former ID |
DIB020935
|
||||
Drug Name |
sergliflozin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [467826] | ||
Structure |
Download2D MOL |
||||
Formula |
C23H28O9
|
||||
InChI |
InChI=1S/C23H28O9/c1-3-29-23(27)30-13-18-19(24)20(25)21(26)22(32-18)31-17-7-5-4-6-15(17)12-14-8-10-16(28-2)11-9-14/h4-11,18-22,24-26H,3,12-13H2,1-2H3/t18-,19-,20+,21-,22-/m1/s1
|
||||
InChIKey |
QLXKHBNJTPICNF-QMCAAQAGSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | SLGT2 | Target Info | Inhibitor | [528482] | |
Sodium/glucose cotransporter 1 | Target Info | Inhibitor | [528482] | ||
PathWhiz Pathway | Lactose Degradation | ||||
Trehalose Degradation | |||||
WikiPathways | NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP2884:NRF2 pathway | |||||
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
Metabolism of carbohydrates | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.